Gene · 3198
Papers1,717
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
441 to 460 of 1,717
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mutant NPM1-regulated lncRNA HOTAIRM1 promotes leukemia cell autophagy and proliferation by targeting EGR1 and ULK3. | J Exp Clin Cancer Res | 2021 | 34615546 | PubTator, text mining | PubMed |
| Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer. | J Clin Lab Anal | 2021 | 34606634 | PubTator, text mining | PubMed |
| Dysregulated expression of circular RNAs serve as diagnostic and prognostic markers in ovarian and cervical cancer: A PRISMA-compliant systematic review and meta-analysis. | Medicine (Baltimore) | 2021 | 34596142 | PubTator, text mining | PubMed |
| Construction and comprehensive analysis of a competitive endogenous RNA network to reveal potential biomarkers for the malignant differentiation of glioma. | Medicine (Baltimore) | 2021 | 34596120 | PubTator, text mining | PubMed |
| Overexpressed lncRNA ROR Promotes the Biological Characteristics of ox-LDL-Induced HUVECs via the let-7b-5p/HOXA1 Axis in Atherosclerosis. | Front Cardiovasc Med | 2021 | 34589524 | PubTator, text mining | PubMed |
| The Role of Non-Coding RNAs in Breast Cancer Drug Resistance. | Front Oncol | 2021 | 34589423 | PubTator, text mining | PubMed |
| The long non-coding RNA HOTAIRM1 promotes tumor aggressiveness and radiotherapy resistance in glioblastoma. | Cell Death Dis | 2021 | 34584066 | PubTator, text mining | PubMed |
| Analytical validation of a novel multi-target blood-based test to detect hepatocellular carcinoma. | Expert Rev Mol Diagn | 2021 | 34581651 | PubTator, text mining | PubMed |
| Molecular Dysregulation in Autism Spectrum Disorder. | J Pers Med | 2021 | 34575625 | PubTator, text mining | PubMed |
| Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis. | Biomedicines | 2021 | 34572451 | PubTator, text mining | PubMed |
| Galectins in Cancer and the Microenvironment: Functional Roles, Therapeutic Developments, and Perspectives. | Biomedicines | 2021 | 34572346 | PubTator, text mining | PubMed |
| The Nucleus/Mitochondria-Shuttling LncRNAs Function as New Epigenetic Regulators of Mitophagy in Cancer. | Front Cell Dev Biol | 2021 | 34568319 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment. | Front Cell Dev Biol | 2021 | 34552922 | PubTator, text mining | PubMed |
| Current and Emerging Tools for Hepatocellular Carcinoma Surveillance. | Hepatol Commun | 2021 | 34533885 | PubTator, text mining | PubMed |
| A putative role for lncRNAs in epigenetic regulation of memory. | Neurochem Int | 2021 | 34530054 | PubTator, text mining | PubMed |
| A Novel Regulatory Player in the Innate Immune System: Long Non-Coding RNAs. | Int J Mol Sci | 2021 | 34502451 | PubTator, text mining | PubMed |
| HOXA1 Is an Antagonist of ERα in Breast Cancer. | Front Oncol | 2021 | 34490074 | PubTator, text mining | PubMed |
| Fluorescent tagging of endogenous Heme oxygenase-1 in human induced pluripotent stem cells for high content imaging of oxidative stress in various differentiated lineages. | Arch Toxicol | 2021 | 34480604 | PubTator, text mining | PubMed |
| Long noncoding RNA SNHG1 promotes TERT expression by sponging miR-18b-5p in breast cancer. | Cell Biosci | 2021 | 34465388 | PubTator, text mining | PubMed |
| Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients. | J Pers Med | 2021 | 34442460 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3198/papers?page=23